We offer the most innovative solution for acute myocardial infarction (AMI) diagnostics

06 March 2023
Semetron AS

Semetron, in co-operation with device manufacturer Siemens Healthineers, offers the most innovative solution for acute myocardial infarction (AMI) diagnostics – the Atellica® VTL. The device is able to determine high-sensitivity troponin I levels in capillary whole blood in a near-patient setting in just 8 minutes. The Atellica® VTLi wireless device can be easily integrated into the workflow of hospitals and clinics. The new solution will help streamline primary diagnostics in overcrowded emergency care centres.

Vaata lähemalt

More news

Announcements
Thistle Scientific Rebranding & product updates

Thistle Scientific has recently undergone a rebranding, with updates to... View Article

New products
Emulants take medical simulations to a new level

Good medical training saves lives. However, if a manikin doesn’t... View Article

New products
Smarter data management for laboratory equipment: Memmert myChamber

In many laboratories, equipment still operates in separate units. This... View Article